Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University; The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Conditions
AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany
  • Universitätsklinikum Marburg Marburg, Germany
  • Klinikum der Universität (LMU) Muenchen Munich, Germany
Enrolling by Invitation

Long-Term Follow-up Study

NCT05332054

Conditions
B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
View all 31 locations